Light Skin Defense Concealer Broad Spectrum Spf 15 Jafra

Octinoxate, Octisalate, Oxybenzone


Jafra Cosmetics International Inc
Human Otc Drug
NDC 68828-170
Light Skin Defense Concealer Broad Spectrum Spf 15 Jafra also known as Octinoxate, Octisalate, Oxybenzone is a human otc drug labeled by 'Jafra Cosmetics International Inc'. National Drug Code (NDC) number for Light Skin Defense Concealer Broad Spectrum Spf 15 Jafra is 68828-170. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Light Skin Defense Concealer Broad Spectrum Spf 15 Jafra drug includes Octinoxate - 7 g/100mL Octisalate - 3 g/100mL Oxybenzone - 2 g/100mL . The currest status of Light Skin Defense Concealer Broad Spectrum Spf 15 Jafra drug is Active.

Drug Information:

Drug NDC: 68828-170
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Light Skin Defense Concealer Broad Spectrum Spf 15 Jafra
Also known as the trade name. It is the name of the product chosen by the labeler.
Proprietary Name Base: Light Skin Defense Concealer Broad Spectrum Spf 15
The base of the Brand/Proprietary name excluding its suffix.
Proprietary Name Suffix: Jafra
A suffix to the proprietary name, a value here should be appended to the ProprietaryName field to obtain the complete name of the product. This suffix is often used to distinguish characteristics of a product such as extended release (“XR”) or sleep aid (“PM”). Although many companies follow certain naming conventions for suffices, there is no recognized standard.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Octinoxate, Octisalate, Oxybenzone
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Jafra Cosmetics International Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cream
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:OCTINOXATE - 7 g/100mL
OCTISALATE - 3 g/100mL
OXYBENZONE - 2 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 22 May, 2013
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 16 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part352
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Jafra Cosmetics International Inc
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:4Y5P7MUD51
4X49Y0596W
95OOS7VE0Y
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
68828-170-021 TUBE in 1 CARTON (68828-170-02) / 15 mL in 1 TUBE (68828-170-01)22 May, 2013N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Uses helps prevent sunburn if used as directed with other sun protection measures (see directions), decreases the risk of skin cancer and early skin aging caused by the sun keep out of reach of children. if product is swallowed, get medical help or contact a poison control center right away. stop use and ask a doctor if rash occurs warnings for external use only do not use on damaged or broken skin when using this product keep out of eyes. rinse with water to remove. directions apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months: ask a doctor sun protection measures. spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with broad spectrum spf of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses inactive ingredients: water/aqua, butylene glycol, glyceryl stearate, stearic acid, isopropyl isostearate, di-ppg-3 myristyl ether adipate, potassium cetyl phosphate, hydrogenated palm glycerides, cetyl alcohol, triethanolamine, lecithin, silica, dimethicone, polysorbate 20, hydrolyzed lupinus albus (lupine) protein, medicago sativa (alfalfa) seed extract, dmdm hydantoin, xanthan gum, biosaccharide gum-4, chondrus crispus (carrageenan) extract, magnesium aluminum silicate, tocopheryl acetate, tagetus erecta (african marigold) extract, ipomoea batatas tuber extract, peg-4 laurate, iodopropynyl butylcarbamate, trisodium edta [may contain +/- : titanium dioxide/ci 77891, iron oxides/ci 77491/ci 77492/ci 77499]

Product Elements:

Light skin defense concealer broad spectrum spf 15 jafra octinoxate, octisalate, oxybenzone water butylene glycol glyceryl monostearate stearic acid isopropyl isostearate di-ppg-3 myristyl ether adipate potassium cetyl phosphate hydrogenated palm glycerides cetyl alcohol trolamine lecithin, soybean silicon dioxide dimethicone polysorbate 20 alfalfa seed dmdm hydantoin xanthan gum chondrus crispus magnesium aluminum silicate .alpha.-tocopherol acetate sweet potato peg-4 laurate iodopropynyl butylcarbamate edetate trisodium titanium dioxide ferric oxide red ferric oxide yellow ferrosoferric oxide octinoxate octinoxate octisalate octisalate oxybenzone oxybenzone medium skin defense concealer broad spectrum spf 15 jafra octinoxate, octisalate, oxybenzone water butylene glycol glyceryl monostearate stearic acid isopropyl isostearate di-ppg-3 myristyl ether adipate potassium cetyl phosphate hydrogenated palm glycerides cetyl alcohol trolamine lecithin, soybean silicon dioxide dimethicone polysorbate 20 alfalfa seed dmdm hydantoin xanthan gum chondrus crispus magnesium aluminum silicate .alpha.-tocopherol acetate sweet potato peg-4 laurate iodopropynyl butylcarbamate edetate trisodium titanium dioxide ferric oxide red ferric oxide yellow ferrosoferric oxide octinoxate octinoxate octisalate octisalate oxybenzone oxybenzone dark skin defense concealer broad spectrum spf 15 jafra octinoxate, octisalate, oxybenzone water butylene glycol glyceryl monostearate stearic acid isopropyl isostearate di-ppg-3 myristyl ether adipate potassium cetyl phosphate hydrogenated palm glycerides cetyl alcohol trolamine lecithin, soybean silicon dioxide dimethicone polysorbate 20 alfalfa seed dmdm hydantoin xanthan gum chondrus crispus magnesium aluminum silicate .alpha.-tocopherol acetate sweet potato peg-4 laurate iodopropynyl butylcarbamate edetate trisodium titanium dioxide ferric oxide red ferric oxide yellow ferrosoferric oxide octinoxate octinoxate octisalate octisalate oxybenzone oxybenzone

Indications and Usage:

Stop use and ask a doctor if rash occurs warnings for external use only do not use on damaged or broken skin when using this product keep out of eyes. rinse with water to remove. directions apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months: ask a doctor sun protection measures. spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with broad spectrum spf of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses inactive ingredients: water/aqua, butylene glycol, glyceryl stearate, stearic acid, isopropyl isostearate, di-ppg-3 myristyl ether adipate, potassium cetyl phosphate, hydrogenated palm glycerides, cetyl alcohol, triethanolamine, lecithin, silica, dimethicone, polysorbate 20, hydrolyzed l
upinus albus (lupine) protein, medicago sativa (alfalfa) seed extract, dmdm hydantoin, xanthan gum, biosaccharide gum-4, chondrus crispus (carrageenan) extract, magnesium aluminum silicate, tocopheryl acetate, tagetus erecta (african marigold) extract, ipomoea batatas tuber extract, peg-4 laurate, iodopropynyl butylcarbamate, trisodium edta [may contain +/- : titanium dioxide/ci 77891, iron oxides/ci 77491/ci 77492/ci 77499]

Warnings:

Warnings for external use only do not use on damaged or broken skin when using this product keep out of eyes. rinse with water to remove. directions apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months: ask a doctor sun protection measures. spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with broad spectrum spf of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses inactive ingredients: water/aqua, butylene glycol, glyceryl stearate, stearic acid, isopropyl isostearate, di-ppg-3 myristyl ether adipate, potassium cetyl phosphate, hydrogenated palm glycerides, cetyl alcohol, triethanolamine, lecithin, silica, dimethicone, polysorbate 20, hydrolyzed lupinus albus (lupine) protein, medicago s
ativa (alfalfa) seed extract, dmdm hydantoin, xanthan gum, biosaccharide gum-4, chondrus crispus (carrageenan) extract, magnesium aluminum silicate, tocopheryl acetate, tagetus erecta (african marigold) extract, ipomoea batatas tuber extract, peg-4 laurate, iodopropynyl butylcarbamate, trisodium edta [may contain +/- : titanium dioxide/ci 77891, iron oxides/ci 77491/ci 77492/ci 77499]

Dosage and Administration:

Directions apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water resistant sunscreen if swimming or sweating children under 6 months: ask a doctor sun protection measures. spending time in the sun increases your risk of skin cancer and early skin aging. to decrease this risk, regularly use a sunscreen with broad spectrum spf of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. - 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses inactive ingredients: water/aqua, butylene glycol, glyceryl stearate, stearic acid, isopropyl isostearate, di-ppg-3 myristyl ether adipate, potassium cetyl phosphate, hydrogenated palm glycerides, cetyl alcohol, triethanolamine, lecithin, silica, dimethicone, polysorbate 20, hydrolyzed lupinus albus (lupine) protein, medicago sativa (alfalfa) seed extract, dmdm hydantoin, xanthan gum, biosaccharide gum-4, chondrus crispus (carrageenan) extract, magnesium aluminum
silicate, tocopheryl acetate, tagetus erecta (african marigold) extract, ipomoea batatas tuber extract, peg-4 laurate, iodopropynyl butylcarbamate, trisodium edta [may contain +/- : titanium dioxide/ci 77891, iron oxides/ci 77491/ci 77492/ci 77499]

Package Label Principal Display Panel:

Light back dark front medium front light front


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.